UNICHEMLAB — Unichem Laboratories Income Statement
0.000.00%
- IN₹42.67bn
- IN₹46.05bn
- IN₹21.11bn
- 39
- 31
- 58
- 37
Annual income statement for Unichem Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 12,351 | 12,698 | 13,430 | 17,049 | 21,110 |
Cost of Revenue | |||||
Gross Profit | 7,649 | 7,512 | 6,698 | 9,331 | 12,473 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12,279 | 12,831 | 15,356 | 17,787 | 19,707 |
Operating Profit | 72.8 | -133 | -1,925 | -738 | 1,403 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 515 | 220 | -1,764 | -617 | 1,546 |
Provision for Income Taxes | |||||
Net Income After Taxes | 343 | 331 | -2,022 | -705 | 1,375 |
Net Income Before Extraordinary Items | |||||
Net Income | 343 | 331 | -2,022 | -705 | 1,375 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 343 | 331 | -2,022 | -705 | 1,375 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.92 | 4.92 | -25.4 | -4.84 | 19.5 |
Dividends per Share |